ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 221 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q1 2022. The put-call ratio across all filers is 1.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,374 | -21.6% | 8,142 | -3.4% | 0.00% | – |
Q2 2023 | $56,579 | -6.4% | 8,432 | +23.2% | 0.00% | – |
Q1 2023 | $60,442 | +14.9% | 6,845 | -0.6% | 0.00% | – |
Q4 2022 | $52,609 | -17.8% | 6,886 | -22.4% | 0.00% | – |
Q3 2022 | $64,000 | +100.0% | 8,876 | +127.6% | 0.00% | – |
Q2 2022 | $32,000 | -56.2% | 3,899 | -26.3% | 0.00% | – |
Q1 2022 | $73,000 | +37.7% | 5,293 | +176.7% | 0.00% | – |
Q4 2021 | $53,000 | -70.4% | 1,913 | -63.5% | 0.00% | – |
Q3 2021 | $179,000 | -43.2% | 5,246 | -32.0% | 0.00% | – |
Q2 2021 | $315,000 | -19.8% | 7,718 | -20.9% | 0.00% | – |
Q1 2021 | $393,000 | -33.2% | 9,760 | -1.7% | 0.00% | -100.0% |
Q4 2020 | $588,000 | +90.3% | 9,924 | +56.0% | 0.00% | – |
Q3 2020 | $309,000 | -4.0% | 6,362 | -4.1% | 0.00% | – |
Q2 2020 | $322,000 | +1688.9% | 6,635 | +922.3% | 0.00% | – |
Q1 2020 | $18,000 | -5.3% | 649 | +1.7% | 0.00% | – |
Q4 2019 | $19,000 | -5.0% | 638 | -0.5% | 0.00% | – |
Q3 2019 | $20,000 | – | 641 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Matrix Capital Management Company, LP | 15,115,090 | $419,897,000 | 10.74% |
TIGER MANAGEMENT L.L.C. | 1,115,411 | $30,986,000 | 10.41% |
Robertson Stephens Wealth Management, LLC | 537,095 | $14,920,000 | 5.10% |
VIKING GLOBAL INVESTORS LP | 33,493,708 | $930,455,000 | 4.84% |
Senator Investment Group LP | 3,388,085 | $94,121,000 | 3.41% |
Casdin Capital, LLC | 793,125 | $22,033,000 | 2.34% |
Iron Triangle Partners LP | 150,000 | $4,167,000 | 1.61% |
Aristotle Atlantic Partners, LLC | 370,841 | $10,302,000 | 1.57% |
Crewe Advisors LLC | 93,000 | $2,584,000 | 1.54% |
PERSONAL CFO SOLUTIONS, LLC | 112,916 | $3,137,000 | 1.13% |